JHS Svendgaard Laboratories Limited (JHS.BO)
INR 22.23
(0.0%)
INR 22.23
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | - INR | 80.17% |
| 2022 | -367.19 Million INR | -399.5% |
| 2021 | -73.51 Million INR | -1068.17% |
| 2020 | -6.29 Million INR | 90.89% |
| 2019 | -69.06 Million INR | -8.24% |
| 2018 | -63.8 Million INR | -189.45% |
| 2017 | 71.33 Million INR | 32.87% |
| 2016 | 53.68 Million INR | 247.38% |
| 2015 | -36.42 Million INR | 75.0% |
| 2014 | -145.72 Million INR | 11.4% |
| 2013 | -164.46 Million INR | -54.26% |
| 2012 | -106.61 Million INR | -222.92% |
| 2011 | 86.73 Million INR | 152.38% |
| 2010 | -165.6 Million INR | -239.2% |
| 2009 | 118.96 Million INR | 174.71% |
| 2008 | 43.3 Million INR | -36.24% |
| 2007 | 67.92 Million INR | 13.22% |
| 2006 | 59.99 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -42 Thousand INR | 99.61% |
| 2023 Q2 | -10.92 Million INR | 77.07% |
| 2023 Q1 | -47.64 Million INR | 7.71% |
| 2023 FY | -72.83 Million INR | 80.17% |
| 2023 Q4 | -10.65 Million INR | 36.74% |
| 2023 Q3 | -16.83 Million INR | -54.1% |
| 2022 FY | -367.19 Million INR | -399.5% |
| 2022 Q1 | -31.6 Million INR | -72.59% |
| 2022 Q2 | -42.3 Million INR | -33.88% |
| 2022 Q3 | -35.48 Million INR | 16.13% |
| 2022 Q4 | -51.62 Million INR | -45.5% |
| 2021 Q3 | -28.47 Million INR | -294.53% |
| 2021 Q2 | -7.21 Million INR | 71.05% |
| 2021 FY | -73.51 Million INR | -1068.17% |
| 2021 Q1 | -24.93 Million INR | -59.73% |
| 2021 Q4 | -18.3 Million INR | 35.71% |
| 2020 Q2 | 14.98 Million INR | 152.32% |
| 2020 Q1 | -28.63 Million INR | -141.31% |
| 2020 FY | -6.29 Million INR | 90.89% |
| 2020 Q4 | -15.6 Million INR | -309.28% |
| 2020 Q3 | 7.45 Million INR | -50.23% |
| 2019 FY | -69.06 Million INR | -8.24% |
| 2019 Q1 | -5.45 Million INR | -173.34% |
| 2019 Q2 | -3.56 Million INR | 34.6% |
| 2019 Q4 | 69.31 Million INR | 1093.89% |
| 2019 Q3 | 5.8 Million INR | 262.68% |
| 2018 Q4 | 7.44 Million INR | -51.65% |
| 2018 Q1 | -5.59 Million INR | -112.67% |
| 2018 FY | -63.8 Million INR | -189.45% |
| 2018 Q3 | 15.38 Million INR | 293.4% |
| 2018 Q2 | -7.95 Million INR | -42.19% |
| 2017 Q3 | 43.12 Million INR | 56.44% |
| 2017 FY | 71.33 Million INR | 32.87% |
| 2017 Q4 | 44.16 Million INR | 2.4% |
| 2017 Q2 | 27.56 Million INR | 537.56% |
| 2017 Q1 | 4.32 Million INR | -76.55% |
| 2016 FY | 53.68 Million INR | 247.38% |
| 2016 Q4 | 18.44 Million INR | -6.45% |
| 2016 Q1 | 4.17 Million INR | 110.66% |
| 2016 Q2 | 15.27 Million INR | 266.29% |
| 2016 Q3 | 19.71 Million INR | 29.04% |
| 2015 Q1 | -12.79 Million INR | 33.72% |
| 2015 FY | -36.42 Million INR | 75.0% |
| 2015 Q4 | 1.98 Million INR | 113.14% |
| 2015 Q2 | -7.42 Million INR | 41.98% |
| 2015 Q3 | -15.06 Million INR | -102.85% |
| 2014 Q3 | -31.59 Million INR | 28.56% |
| 2014 Q1 | -51.26 Million INR | -1227.23% |
| 2014 FY | -145.72 Million INR | 11.4% |
| 2014 Q4 | -19.31 Million INR | 38.87% |
| 2014 Q2 | -44.22 Million INR | 13.75% |
| 2013 Q3 | -44.31 Million INR | 18.5% |
| 2013 FY | -164.46 Million INR | -54.26% |
| 2013 Q1 | -34.06 Million INR | -78.12% |
| 2013 Q2 | -54.37 Million INR | -59.6% |
| 2013 Q4 | -3.86 Million INR | 91.28% |
| 2012 Q1 | 68.17 Million INR | 0.0% |
| 2012 Q4 | -19.12 Million INR | -80.45% |
| 2012 Q2 | 4.6 Million INR | -93.25% |
| 2012 Q3 | -10.59 Million INR | -330.31% |
| 2012 FY | -106.61 Million INR | -222.92% |
| 2011 FY | 86.73 Million INR | 152.38% |
| 2010 FY | -165.6 Million INR | -239.2% |
| 2009 FY | 118.96 Million INR | 174.71% |
| 2008 FY | 43.3 Million INR | -36.24% |
| 2007 FY | 67.92 Million INR | 13.22% |
| 2006 FY | 59.99 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Ador Multiproducts Limited | -10.12 Million INR | 100.0% |
| Ambica Agarbathies Aroma & Industries Limited | 21.09 Million INR | 100.0% |
| Bajaj Consumer Care Limited | 1.45 Billion INR | 100.0% |
| Colgate-Palmolive (India) Limited | 17.32 Billion INR | 100.0% |
| Cupid Limited | 938.79 Million INR | 100.0% |
| Dabur India Limited | 36.93 Billion INR | 100.0% |
| Emami Limited | 12.94 Billion INR | 100.0% |
| Gillette India Limited | 9.81 Billion INR | 100.0% |
| Godrej Consumer Products Limited | - INR | NaN% |
| Hindustan Unilever Limited | 222.97 Billion INR | 100.0% |
| Hipolin Limited | - INR | NaN% |
| Honasa Consumer Limited | 4.96 Billion INR | 100.0% |
| Jyothy Labs Limited | 4.44 Billion INR | 100.0% |
| Kaya Limited | -317.11 Million INR | 100.0% |
| Marico Limited | 18.71 Billion INR | 100.0% |
| N.K Industries Limited | -43.03 Million INR | 100.0% |
| PAOS INDUSTRIES LIMITED | -513 Thousand INR | 100.0% |
| Paramount Cosmetics (India) Limited | -2.22 Million INR | 100.0% |
| Pee Cee Cosma Sope Limited | 139.37 Million INR | 100.0% |
| Procter & Gamble Hygiene and Health Care Limited | 17.77 Billion INR | 100.0% |